Retiform Plaques: An Additional Diagnostic Consideration

Main Article Content

Hannah Mumber
Jimmy Lam
Lynne Goldberg
Christina Lam


retiform plaques, linear morphea, diagnostic challenge, quality of life, autoimmune condition


1. “The Skin in Immune, Autoimmune, Autoinflammatory, and Rheumatic Disorders.” Fitzpatrick's Color Atlas and Synopsis of Clinical Dermatology, by Klaus Wolff et al., McGraw-Hill Education, 2017, pp. 343–364.

2. Ee HL, Tan SH. Reticulate hyperpigmented scleroderma: a new pigmentary manifestation. Clin Exp Dermatol. 2005;30(2):131-133. doi:10.1111/j.1365-2230.2004.01683.x

3. Weibel L, Harper JI. Linear morphoea follows Blaschko’s lines. Br J Dermatol. 2008;159(1):175-181. doi:10.1111/j.1365-2133.2008.08647.x

4. Wolf R, Wolf D, Ruocco E, et al. Wolf’s isotopic response. Clin Dermatol. 2011;29(2):237-240. doi:10.1016/j.clindermatol.2010.09.015

5. Sartori-Valinotti JC, Tollefson MM, Reed AM. Updates on morphea: role of vascular injury and advances in treatment. Autoimmune Dis. 2013;467808. doi:10.1155/2013/467808

6. O’Brien JC, Nymeyer H, Green A, et al. Changes in disease activity and damage over time in patients with morphea. JAMA Dermatology. April 2020. doi:10.1001/jamadermatol.2020.0034